BG108673A - Pharmaceutical composition comprising gamma-butyrobetaine - Google Patents

Pharmaceutical composition comprising gamma-butyrobetaine

Info

Publication number
BG108673A
BG108673A BG108673A BG10867304A BG108673A BG 108673 A BG108673 A BG 108673A BG 108673 A BG108673 A BG 108673A BG 10867304 A BG10867304 A BG 10867304A BG 108673 A BG108673 A BG 108673A
Authority
BG
Bulgaria
Prior art keywords
butyrobetaine
gamma
disclosed
erection
pharmaceutical compositions
Prior art date
Application number
BG108673A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ivars Kalvinsh
Maris Veveris
Anatolijs Birmans
Original Assignee
Ivars Kalvinsh
Maris Veveris
Anatolijs Birmans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivars Kalvinsh, Maris Veveris, Anatolijs Birmans filed Critical Ivars Kalvinsh
Publication of BG108673A publication Critical patent/BG108673A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG108673A 2001-09-07 2004-04-07 Pharmaceutical composition comprising gamma-butyrobetaine BG108673A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-01-134A LV12979B (en) 2001-09-07 2001-09-07 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
BG108673A true BG108673A (en) 2005-03-31

Family

ID=19735292

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108673A BG108673A (en) 2001-09-07 2004-04-07 Pharmaceutical composition comprising gamma-butyrobetaine

Country Status (30)

Country Link
US (1) US20040242590A1 (ja)
EP (1) EP1429753B1 (ja)
JP (1) JP4382480B2 (ja)
KR (1) KR100841035B1 (ja)
CN (1) CN1275595C (ja)
AR (1) AR036423A1 (ja)
AT (1) ATE350029T1 (ja)
AU (1) AU2002236340B2 (ja)
BG (1) BG108673A (ja)
CA (1) CA2459719C (ja)
CU (1) CU23347B6 (ja)
DE (1) DE60217369T2 (ja)
DK (1) DK1429753T3 (ja)
EA (1) EA006675B1 (ja)
ES (1) ES2280505T3 (ja)
HK (1) HK1068003A1 (ja)
HR (1) HRPK20040328B3 (ja)
IL (2) IL160734A0 (ja)
JO (1) JO2507B1 (ja)
LV (1) LV12979B (ja)
MA (1) MA27683A1 (ja)
MX (1) MXPA04002050A (ja)
MY (1) MY134074A (ja)
NZ (1) NZ532178A (ja)
PL (1) PL368758A1 (ja)
PT (1) PT1429753E (ja)
SI (1) SI1429753T1 (ja)
TW (1) TWI224506B (ja)
WO (1) WO2003022262A1 (ja)
ZA (1) ZA200402702B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10325813B4 (de) * 2003-06-06 2007-12-20 Universitätsklinikum Freiburg Prophylaxe und/oder Therapie bei der portalen Hypertonie
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
KR20080047375A (ko) 2005-07-29 2008-05-28 콘서트 파마슈티컬즈, 인크. 약제 화합물
WO2009095445A1 (en) * 2008-01-29 2009-08-06 Grindeks New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate
CN101781302B (zh) * 2009-05-31 2013-07-10 段波 一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用
RU2622757C1 (ru) * 2016-06-02 2017-06-19 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ лечения эректильной дисфункции

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (it) * 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Also Published As

Publication number Publication date
HK1068003A1 (en) 2005-04-22
EA200400386A1 (ru) 2004-08-26
MA27683A1 (fr) 2006-01-02
IL160734A0 (en) 2004-08-31
ZA200402702B (en) 2005-05-11
SI1429753T1 (sl) 2007-06-30
JP4382480B2 (ja) 2009-12-16
KR20040034704A (ko) 2004-04-28
ATE350029T1 (de) 2007-01-15
HRP20040328A2 (en) 2004-08-31
DE60217369T2 (de) 2007-08-23
IL160734A (en) 2009-09-22
AR036423A1 (es) 2004-09-08
HRPK20040328B3 (en) 2006-02-28
TWI224506B (en) 2004-12-01
KR100841035B1 (ko) 2008-06-24
MXPA04002050A (es) 2004-06-07
CA2459719C (en) 2010-07-06
JP2005504071A (ja) 2005-02-10
CN1275595C (zh) 2006-09-20
JO2507B1 (en) 2009-10-05
PL368758A1 (en) 2005-04-04
AU2002236340B2 (en) 2008-06-12
DK1429753T3 (da) 2007-05-14
WO2003022262A1 (en) 2003-03-20
EP1429753B1 (en) 2007-01-03
CA2459719A1 (en) 2003-03-20
PT1429753E (pt) 2007-04-30
LV12979B (en) 2003-05-20
MY134074A (en) 2007-11-30
EA006675B1 (ru) 2006-02-24
CU23347B6 (es) 2009-02-20
EP1429753A1 (en) 2004-06-23
US20040242590A1 (en) 2004-12-02
ES2280505T3 (es) 2007-09-16
CN1551764A (zh) 2004-12-01
DE60217369D1 (de) 2007-02-15
NZ532178A (en) 2007-05-31

Similar Documents

Publication Publication Date Title
MXPA03005464A (es) Agentes antivirales.
SG153830A1 (en) Galenic formulations of organic compounds
YU69902A (sh) Novi derivati piperazina
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
HU0102272D0 (en) Compositions and methods for stimulating gastrointestinal motilis
MA26861A1 (fr) Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
HUP9802678A2 (hu) Biciklusos aminszármazékok és ezeket tartalmazó PGD2 antagonista hatású készítmények
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
HUP0100870A2 (hu) Analgetikumokként alkalmazható alfa-amino-amid-származékok
HK1068003A1 (en) Pharmaceutical composition comprising gamma-butyrobetaine
WO2004005324A3 (en) Peptide composition for treatment of sexual dysfunction
WO2005014617A3 (en) Cyclic peptide compositions and methods for treatment of sexual dysfunction
SE9802206D0 (sv) Novel compounds
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
EP0992240A4 (en) THERAPEUTIC AGENT FOR TREATING ANERECTION
PL356237A1 (en) Pyrimidine derivatives as selective inhibitors of cox-2
HUP0300615A2 (hu) Sibutramint és orlistatot tartalmazó gyógyszerkészítmény
SE0004101D0 (sv) New use
ATE218535T1 (de) Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung
WO2002024661A3 (en) New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
EP1616862A4 (en) HETEROCYCLIC NITROGEN COMPOUND AND USE THEREOF
WO2004010924A3 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
AP2002002595A0 (en) Heterocyclic amide derivatives.